Our study identified a relationship between kallistatin and androgen levels in PCOS groups, suggesting that kallistatin could be used as a diagnostic marker and for monitoring PCOS, where androgens play a central role in its etiopathogenesis. This evidence concerns the gene SERPINA4 and polycystic ovary syndrome.